Description:

North Central Cancer Treatment Group N0577 Nadir/Adverse Event Form Radiation Therapy or Radiation Therapy and Temozolomide or Temozolomide Alone in Treating Patients With Newly Diagnosed Anaplastic Glioma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4C094A66-12E0-40DD-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4C094A66-12E0-40DD-E044-0003BA3F9857

Keywords:
Versions (5) ▾
  1. 8/26/12
  2. 1/8/15
  3. 1/9/15
  4. 1/9/15
  5. 1/10/15
Uploaded on:

January 10, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Brain and Central Nervous System Tumors NCT00887146 Toxicity - North Central Cancer Treatment Group N0577 Nadir/Adverse Event Form - 2745613v1.0

Details

No Instruction available.

  1. StudyEvent: North Central Cancer Treatment Group N0577 Nadir/Adverse Event Form
    1. No Instruction available.
Header
Are data amended (If yes, highlight amended areas)
Header
1000/uL
1000/uL
CTC AE Attribution Code (If Grade > 0)
g/dL
Has an Adverse Event Expedited Report been submitted? (Enter 1 for Yes or 2 for No)
Is nadir below LLN? (check one)
Description Of Primary Disease
CTC Adverse Event Term
CTC AE Attribution Code (If Grade > 0)
Has an Adverse Event Expedited Report been submitted? (Enter 1 for Yes or 2 for No)
Were adverse events assessed during this report period (other)
Description Of Primary Disease
CTC AE Attribution Code (If Grade > 0)
Has an Adverse Event Expedited Report been submitted? (Enter 1 for Yes or 2 for No)
Back to the top of the page